Breaking News, Collaborations & Alliances

Schrödinger, WuXi AppTec Enter Drug Discovery Tie-up

Announce the launch of Faxian Therapeutics to enable accelerated drug discovery

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Schrödinger, a privately-held drug discovery firm, and WuXi AppTec, a pharmaceutical and medical device R&D enabling platform company, have formed Faxian Therapeutics. The new venture will leverage the precision molecular design platforms developed by Schrödinger and accelerate them through partnership with the optimization services provided by WuXi AppTec.   Headquartered in New York City, Faxian Therapeutics will identify opportunities where new insights into the chemistry and biology of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters